Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06676267

Laparoscopic Surgical Systems for Gynecological and Remote Surgical Treatment.

Exploratory Study on the Application of Laparoscopic Surgical Systems for Gynecological and Remote Surgical Treatment.

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
5 (estimated)
Sponsor
Affiliated Hospital of Nantong University · Academic / Other
Sex
Female
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Remote robot-assisted laparoscopic surgery will be performed for gynecological surgical treatment through 5G network, while the safety and effectiveness will be studied.

Detailed description

This clinical study adopts a prospective, single-center, single-arm exploratory design. Remote robot-assisted laparoscopic surgery will be performed for gynecological surgical treatment through 5G network, while the safety and effectiveness will be studied. The research process consists of three stages: the screening phase, the treatment phase and the follow-up phase. The screening phase: On the premise of meeting the inclusion and exclusion criteria, patients who voluntarily participate in robot-assisted surgery are planned to be included. Obtain written informed consent from the subjects, collect clinical data (which may include previous medical examination results), and complete relevant examinations. The treatment phase: The laparoscopic surgical system is combined with 5G network and communication technology for the surgical operation process. The follow-up phase: The physician's observational follow-up of the subjects in the study will continue up to one month post-surgery, and may be extended if necessary. During these three phases, subjects will need to undergo some medical observations or examinations to assess safety and efficacy indicators.

Conditions

Interventions

TypeNameDescription
PROCEDURELaparoscopic surgeryThe laparoscopic surgery system is applied to gynecology and 5G remote surgical treatment.

Timeline

Start date
2024-08-01
Primary completion
2026-08-31
Completion
2026-10-31
First posted
2024-11-06
Last updated
2025-01-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT06676267. Inclusion in this directory is not an endorsement.